Relation

We were deeply honoured to have Sir Paul Nurse @TheCrick join us to officially open our flagship integrated dry-wet lab in London's @KQ_London . Thank you Sir Paul Nurse for your inspirational speech and joining our CEO @welshmanofkent inaugurating our magnificent new home!

Wow! This is so cool and way more fun than boring BioRender! Plus, developing fine motor skills through hand drawing and creativity without limitations in shapes or form! Try it out yourself here chat.figurelabs.ai/invitation/inv…

‘Lab-in-the-loop’ approach seeks to ensure targets are causally linked in bone health, immunology and metabolic disease. longevity.technology/news/relation-… #longevity #biotech #investment #osteoporosis #bonedisease #aging

Today we’re announcing a new collaboration between @RelationRx and @Novartis to accelerate the discovery of drug targets for atopic diseases. These conditions affect hundreds of millions of people globally, and better understanding their underlying biology is essential to delivering more effective medicines. As our CEO David Roblin shared today in Bloomberg, too many programmes fail because we don’t yet understand the biology well enough at the start. This partnership brings together Novartis’ strength in immunology with Relation’s patient-derived data and AI platform to help change that. The patient is waiting. bloomberg.com/news/articles/… globenewswire.com/news-release/2…

Huge achievement by the Rosalind team at @RelationRx showing our now award-winning SOTA approach to DNA transformer models 🔥 Join us at @NeurIPSConf #NeurIPS and meet us in person: @wildtypehuman, @cristianregep, Lindsay Edwards, Rosie Rodriguez, Sara-Jane Dunn, and Alice Del Vecchio!

In the last few years I’ve built a DNA modelling team in industry @RelationRx. Our recent work just won 🏆 Best Paper at the @AI4D3 workshop at #NeurIPS, and we’ll be giving a talk. A few co-authors and I will be in San Diego this week and would love to connect with others passionate about DNA modelling. 🎤 Dec 6th, — San Diego Convention Center, Upper Level, Room 28A–E 🔗 Read the paper: biorxiv.org/content/10.110…

Heading to San Diego for #NeurIPS2025 , ping me if you want to chat on active learning, reinforcement learning, and applications of deep learning in genomics (single cell, spatial, etc).

Hiring someone for a very exciting project at the intersection of wet-lab and dry-lab. Generating spatial transcriptomics data and then analysing it. You need to be happy to get your hands dirty...!

Relation co-founder Jake Taylor-King (@wildtypehuman) speaking at @SlushHQ on how AI will transform drug discovery!

At @raais 2025, Benjamin Swerner Co-Founder and COO of @RelationRx reflected on why this century will be defined by two breakthroughs: building intelligence independent of humans and reducing the world’s disease burden. Be part of the community at raais(dot)co, rsvps open!

This is an amazing line up! Come one and all :D

We’re thrilled to announce that the "High-Content CRISPR Screening" conference will take place on March 18–19, 2026, in Vienna, Austria. The registration is now open via the website: perturb2026.bio Meet the Speaker: Jake P. Taylor-King @wildtypehuman @RelationRx

AI is accelerating the future of medicine. NVIDIA is collaborating with healthcare and life sciences leaders across the UK to unlock faster, more precise drug discovery. From Hologen’s complex human biology models and @RelationRx lab-in-the-loop experimentation, to @InSilicoUK’s digital twins and @Basecamp_Res’s expansive datasets—AI is powering breakthroughs that bring new therapies closer to patients. The next era of healthcare starts here.

Making AI useful in the lab: the missing math of active learning A call for greater first-principles theory to power lab-in-the-loop science with @BlackHC and @paulmorio

With Paul Scherer of @RelationRx and Andreas Kirsch (@BlackHC) we give our take on how to exploit a very simple relationship (the bias-variance tradeoff) to build a class of general AL strategies. arxiv.org/abs/2509.04363

Much of the active learning literature avoids modelling the bias and noise of the underlying experimental system...

Relationships That Make TechBio Go 'Round. Listen to David Roblin, CEO of @RelationRx on The Long Run. timmermanreport.com/2025/03/relati…

I love seeing @RelationRx's term "lab-in-the-loop" making it into the modern parlance!

Read the @scTrends_update take on the AI arms race to generate single-cell data sctrends.org/p/the-single-c… Thanks @AdamCribbs !

How big a market do early stage VCs think there actually is for protein foundation models? Remember, the key cost and hurdle is clinical trails, not a lack of molecules to try drugging people with. (Side note: we need new targets and that's what @RelationRx is about)

🚀 Have You Read the UK biotech financing report yet? ➡️ biotechfinance.org Our latest #UKbiotech financing report is packed with inspiring case studies of groundbreaking companies securing funding to drive 🚀 innovation, fuel R&D, and strengthen the UK’s position as a #GlobalBiotech leader 👏 A great example is @RelationRx, which closed an impressive $60 million seed round last year—a testament to the sector’s resilience and growth 📖 Dive into the report to discover more success stories and see how the UK is maintaining its competitive edge in #biotech ➡️ biotechfinance.org Special thanks to David Roblin, CEO of @RelationRx for his thoughts 🧠 #InvestinBiotech